Knipper Blog Direct-to-Patient Sample Distribution in the Time of COVID-19

By John C. Petrolino & John Maher The Public Health Emergency (PHE) allowed for a temporary abeyance of the Prescription Drug Marketing Act's (PDMA's) requirement that drug samples be provided to physicians prior to subsequent distribution to patients. The ability for physicians to direct drug companies to provide samples directly to patients leverages accepted telehealth [...]The post Direct-to-Patient Sample Distribution in the Time of COVID-19 appeared first on Knipper.